Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-07

Clinical Trial Update: The Effects of Using Yupingfeng Powder with Variation for the Treatment of Allergic Rhinitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a variation of Yupingfeng Powder for allergic rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Yupingfeng Powder (variation)

Snippet

Sponsor: Prof. Lin Zhixiu | Conditions: Allergic Rhinitis | Phase 2 | Status: COMPLETED